We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Acute Coronary Syndrome in the COVID-19 Era—Differences and Dilemmas Compared to the Pre-COVID-19 Era.
- Authors
Lasica, Ratko; Djukanovic, Lazar; Mrdovic, Igor; Savic, Lidija; Ristic, Arsen; Zdravkovic, Marija; Simic, Dragan; Krljanac, Gordana; Popovic, Dejana; Simeunovic, Dejan; Rajic, Dubravka; Asanin, Milika
- Abstract
The COVID-19 pandemic has led to numerous negative implications for all aspects of society. Although COVID-19 is a predominant lung disease, in 10–30% of cases, it is associated with cardiovascular disease (CVD). The presence of myocardial injury in COVID-19 patients occurs with a frequency between 7–36%. There is growing evidence of the incidence of acute coronary syndrome (ACS) in COVID-19, both due to coronary artery thrombosis and insufficient oxygen supply to the myocardium in conditions of an increased need. The diagnosis and treatment of patients with COVID-19 and acute myocardial infarction (AMI) is a major challenge for physicians. Often the presence of mixed symptoms, due to the combined presence of COVID-19 and ACS, as well as possible other diseases, nonspecific changes in the electrocardiogram (ECG), and often elevated serum troponin (cTn), create dilemmas in diagnosing ACS in COVID-19. Given the often-high ischemic risk, as well as the risk of bleeding, in these patients and analyzing the benefit/risk ratio, the treatment of patients with AMI and COVID-19 is often associated with dilemmas and difficult decisions. Due to delays in the application of the therapeutic regimen, complications of AMI are more common, and the mortality rate is higher.
- Subjects
ACUTE coronary syndrome; COVID-19; COVID-19 pandemic; MYOCARDIAL injury; CORONARY thrombosis; MYOCARDIAL infarction
- Publication
Journal of Clinical Medicine, 2022, Vol 11, Issue 11, p3024
- ISSN
2077-0383
- Publication type
Article
- DOI
10.3390/jcm11113024